Bionano Genomics (BNGO) Non-Current Deffered Revenue (2017 - 2026)
Bionano Genomics (BNGO) reported Non-Current Deffered Revenue of $143000.0 for Q1 2026, down 51.03% on a YoY basis from $292000.0 in Q1 2025, and down 42.57% sequentially from $249000.0 in Q4 2025.
Bionano Genomics (BNGO) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
Bionano Genomics (BNGO) has 10 years of Non-Current Deffered Revenue data on file, last reported at $143000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deffered Revenue fell 51.03% year-over-year to $143000.0; the trailing twelve-month figure through Mar 2026 stood at $143000.0 (down 51.03% YoY), and the FY2025 full-year result was $249000.0, down 6.74% from the prior year.
- Non-Current Deffered Revenue slipped to $143000.0 in Q1 2026, from $249000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $292000.0 in Q1 2025 to a low of $127000.0 in Q4 2022.
- A 5-year average of $196647.1 and a median of $192000.0 in 2025 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue soared 111.59% in 2025 and sank 51.03% in 2026, its largest moves.
- Tracing BNGO's Non-Current Deffered Revenue over 5 years: stood at $127000.0 in 2022, then grew by 21.26% to $154000.0 in 2023, then soared by 73.38% to $267000.0 in 2024, then dropped by 6.74% to $249000.0 in 2025, then plunged by 42.57% to $143000.0 in 2026.
- Business Quant data shows BNGO's Non-Current Deffered Revenue at $143000.0 in Q1 2026, $249000.0 in Q4 2025, and $192000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 163.15 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Bionano Genomics | 4.34 Mn | -9.35 Mn | 3.25 Mn | 143,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 192,000.00 |
| Jun 30, 2025 | 243,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | 267,000.00 |
| Sep 30, 2024 | 263,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Sep 30, 2023 | 151,000.00 |
| Jun 30, 2023 | 186,000.00 |
| Mar 31, 2023 | 194,000.00 |
| Dec 31, 2022 | 127,000.00 |
| Sep 30, 2022 | 136,000.00 |
| Jun 30, 2022 | 203,000.00 |
| Mar 31, 2022 | 133,000.00 |
| Dec 31, 2021 | 146,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 213,000.00 |